EU regulators accept Novartis’ triple asthma comboEuropean regulators have accepted Novartis’ filing for a triple combination therapy for asthma known as QVM149, triggering payments Share XEU regulators accept Novartis’ triple asthma combohttps://pharmaphorum.com/news/eu-regulators-accept-novartis-triple-asthma-combo/
Shingles vaccine boosts GSK as generic Advair bitesGSK’s first quarter sales beat estimates, helped along by shingles vaccine Shingrix and partly offsetting the effect of Share XShingles vaccine boosts GSK as generic Advair biteshttps://pharmaphorum.com/news/shingles-vaccine-boosts-gsk-as-generic-advair-bites/
GSK and digital disruption: the pharmaphorum podcastDigital innovation and disruption in healthcare are the subject of this episode of the pharmaphorum podcast, for which Share XGSK and digital disruption: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/gsk-digital-disruption
GSK adds to COPD pipeline as Exscientia deal bears fruitAI drug research firm Exscientia has delivered the first candidate molecule to its partner GlaxoSmithKline following an R&D Share XGSK adds to COPD pipeline as Exscientia deal bears fruithttps://pharmaphorum.com/about-pharmaphorum/gsk-adds-to-copd-pipeline-as-exscientia-deal-bears-fruit/
GSK mulls filings for multiple myeloma drugGlaxoSmithKline has announced more data making the case for its multiple myeloma antibody-drug conjugate GSK2857916, confirming that almost Share XGSK mulls filings for multiple myeloma drughttps://pharmaphorum.com/news/gsk-mulls-filings-for-multiple-myeloma-drug/
GSK bolts-on immuno-oncology candidate with €3.7bn Merck dealGlaxoSmithKline is making another big play in cancer, signing a wide-ranging deal with Merck KGaA for M7824, an Share XGSK bolts-on immuno-oncology candidate with €3.7bn Merck dealhttps://pharmaphorum.com/news/gsk-bolts-on-immuno-oncology-candidate-with-e3-7bn-merck-deal/
FDA finally approves Mylan’s Advair genericThe FDA has finally approved the first generic of GlaxoSmithKline’s Advair blockbuster respiratory diseases inhaler, after years of Share XFDA finally approves Mylan’s Advair generichttps://pharmaphorum.com/news/fda-finally-approves-mylans-advair-generic/
AZ’s new COPD inhaler Bevespi Aerosphere approved in EUAstraZeneca’s new inhaler Bevespi Aerosphere (glycopyrronium/formoterol fumarate) has been approved in Europe, as a maintenance treatment for chronic Share XAZ’s new COPD inhaler Bevespi Aerosphere approved in EUhttps://pharmaphorum.com/news/astrazeneca-copd-bevespi-aerosphere/
GSK/Pfizer form consumer health joint ventureGlaxoSmithKline has announced its second major deal this month, signing an agreement with Pfizer to combine its consumer Share XGSK/Pfizer form consumer health joint venturehttps://pharmaphorum.com/news/gsk-pfizer-form-consumer-health-joint-venture/
